<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04576468</url>
  </required_header>
  <id_info>
    <org_study_id>FDAS-RecIM011735</org_study_id>
    <nct_id>NCT04576468</nct_id>
  </id_info>
  <brief_title>The Use of Leucocyte Platelet Rich Fibrin (L- PRF) Covered Perforated Guided Tissue Membrane for Treatment of Periodontal Intrabony Defects</brief_title>
  <official_title>The Use of Leucocyte Platelet Rich Fibrin (L- PRF) Covered Perforated Guided Tissue Membrane for Treatment of Periodontal Intrabony Defects (Randomized Clinical Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Future University in Egypt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is the first to investigate the effect of leucocyte platelet rich fibrin (L-PRF)&#xD;
      combined with perforated membrane in order to treat infrabony defects and assess their&#xD;
      combined effect in clinical attachment level gain and filling of base of the defect (BD). The&#xD;
      main hypothesis was that if the L-PRF act as a chemoattracttant for a higher number of&#xD;
      periosteal derived periodontal cells (PDPCs) and gingival mesenchymal stem cells (GMSCs)&#xD;
      encouraging their passage through the membrane perforations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized (controlled) clinical trial which included forty sites with intrabony&#xD;
      interproximal defects (2- or 3-wall) premolar/molar teeth assessed for clinical parameters.&#xD;
      The four treatment modalities were randomly allocated by a predetermined computer generated&#xD;
      randomization list (www.randomizer.org) into four equal groups; Group I (control group) open&#xD;
      flap debridement (OFD): included intrabony defects treated by open flap debridement&#xD;
      (OFD).Group II perforated membrane (PM): included intrabony defects treated by perforated&#xD;
      membranes.Group III Leucocyte-platelet rich fibrin (L-PRF): included intrabony defects&#xD;
      treated by leukocytes platelet rich fibrin (L-PRF). Group IV Leucocyte-platelet rich fibrin +&#xD;
      perforated membrane (L-PRF + PM): included intrabony defects treated by Leucocyte platelet&#xD;
      rich fibrin &amp; perforated membranes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>patients equally distributed into 4 groups</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical attachement level gain</measure>
    <time_frame>6 month</time_frame>
    <description>measured using University of North Carolina Periodontal probe change from baseline at 6 month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>radiographic bone fill</measure>
    <time_frame>6 month</time_frame>
    <description>measured using standardized periapical radiograph change from baseline at 6 month</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Periodontal Diseases</condition>
  <arm_group>
    <arm_group_label>open flap debridement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>envelope full thickness flap reflection, removal of granulation tissue then suturing with simple loop sutures.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>perforated membrane (PM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>envelope full thickness flap reflection, removal of granulation tissue placing resorbable membrane after perforating it over the vertical defect then suturing with simple loop sutures.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>leucocyte platelet rich fibrin (L-PRF)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>envelope full thickness flap reflection, removal of granulation tissue after withdrawal of blood and placing it in intraspin centrifuge , placing the resulting L-PRF in the defect then suturing with simple loop sutures.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>L-PRF + PM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>envelope full thickness flap reflection, removal of granulation tissue after withdrawal of blood and placing it in intraspin centrifuge , placing the resulting L-PRF covered by resorbable membrane after perforating it in the defect then suturing with simple loop sutures.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open flap debridement</intervention_name>
    <description>Surgical intevention</description>
    <arm_group_label>L-PRF + PM</arm_group_label>
    <arm_group_label>leucocyte platelet rich fibrin (L-PRF)</arm_group_label>
    <arm_group_label>open flap debridement</arm_group_label>
    <arm_group_label>perforated membrane (PM)</arm_group_label>
    <other_name>OFD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>perforated membrane</intervention_name>
    <description>surgical intervention</description>
    <arm_group_label>L-PRF + PM</arm_group_label>
    <arm_group_label>perforated membrane (PM)</arm_group_label>
    <other_name>perforated guided tissue membrane</other_name>
    <other_name>regenerative surgery</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>leucocyte - platelet rich fibrin</intervention_name>
    <description>surgical intervention</description>
    <arm_group_label>L-PRF + PM</arm_group_label>
    <arm_group_label>leucocyte platelet rich fibrin (L-PRF)</arm_group_label>
    <other_name>L-PRF</other_name>
    <other_name>regenerative surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Both genders aged from 18- 60 years.&#xD;
&#xD;
          -  Patients free from any systemic diseases that may contra-indicate periodontal surgery&#xD;
             (Ahmed Y. Gamal et al., 2014).&#xD;
&#xD;
          -  Two- or three-wall intrabony defects in premolar/molar teeth without furcation&#xD;
             involvement, that are measured from the alveolar crest to the defect bottom in&#xD;
             diagnostic periapical radiographs of ≥ 3 mm (Reynolds et al., 2015).&#xD;
&#xD;
          -  Probing depth ≥ 5 mm and clinical attachment loss ≥ 4 mm at the site of intrabony&#xD;
             defects 4 week after the phase one therapy (Ahmed Y. Gamal et al., 2014).&#xD;
&#xD;
          -  Free from any periapical pathosis.&#xD;
&#xD;
          -  Patients willing and able to return for multiple follow up visits and perform oral&#xD;
             hygiene instructions.&#xD;
&#xD;
          -  Absence of occlusal interference, mobility and open interproximal contact.&#xD;
&#xD;
          -  Good fulfillment to plaque control instructions following initial therapy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers.&#xD;
&#xD;
          -  Pregnant and breast feeding females.&#xD;
&#xD;
          -  Periodontal surgical treatment in the previous 12 months at the involved sites. (A. Y.&#xD;
             Gamal et al., 2016)&#xD;
&#xD;
          -  Persistence of gingival inflammation after phase I therapy.&#xD;
&#xD;
          -  Vulnerable groups as handicapped, mentally disabled, prisoners and orphans.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Y Gamal, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of dentistry - Ain shams University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of dentistry Ain shams University</name>
      <address>
        <city>Cairo</city>
        <zip>1156</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 28, 2020</study_first_submitted>
  <study_first_submitted_qc>October 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2020</study_first_posted>
  <last_update_submitted>October 5, 2020</last_update_submitted>
  <last_update_submitted_qc>October 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mariam Samir</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>perforated membrane</keyword>
  <keyword>L-PRF</keyword>
  <keyword>guided tissue regeneration</keyword>
  <keyword>vertical defects</keyword>
  <keyword>Intrabony defects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

